Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states

被引:132
作者
Cassell, OCS
Hofer, SOP
Morrison, WA
Knight, KR
机构
[1] St Vincents Hosp, Bernard OBrien Inst Microsurg, Fitzroy, Vic 3065, Australia
[2] Radcliffe Infirm, Dept Plast & Reconstruct Surg, Oxford OX2 6HE, England
[3] Univ Rotterdam Hosp, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands
来源
BRITISH JOURNAL OF PLASTIC SURGERY | 2002年 / 55卷 / 08期
基金
英国医学研究理事会;
关键词
tissue engineering; grafts; angiogenesis; vasculogenesis; reconstructive surgery;
D O I
10.1054/bjps.2002.3950
中图分类号
R61 [外科手术学];
学科分类号
摘要
Angiogenesis (the formation of new blood vessels) is essential for the growth of new tissue, tissue repair and wound healing. Tissue engineering, the 'construction of new tissue and organs for reparative purposes, relies on angiogenesis for the vascularisation of these new grafts. In tissue engineering, the emphasis to date has been on vascularisation of newly constructed tissue grafts by an extrinsic blood supply, and relatively little attention has been given to the possibility of building these grafts around an intrinsic blood supply. However, there are many disease processes, notably tumour growth, where excess angiogenesis can be a major problem. The purposes of this review are, first, to examine various methods of vascularising tissue-engineered grafts, and, second, to compare the role of angiogenesis in tissue engineering, where stimulation of angiogenesis is paramount, with pathological states, such as tumour growth, where angiogenesis needs to be inhibited. (C) 2002 The British Association of Plastic Surgeons. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:603 / 610
页数:8
相关论文
共 79 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[2]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[3]   FORMATION OF UROTHELIAL STRUCTURES INVIVO FROM DISSOCIATED CELLS ATTACHED TO BIODEGRADABLE POLYMER SCAFFOLDS INVITRO [J].
ATALA, A ;
VACANTI, JP ;
PETERS, CA ;
MANDELL, J ;
RETIK, AB ;
FREEMAN, MR .
JOURNAL OF UROLOGY, 1992, 148 (02) :658-662
[4]  
BATTEGAY EJ, 1995, J MOL MED, V73, P333
[5]   Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].
Baumgartner, I ;
Pieczek, A ;
Manor, O ;
Blair, R ;
Kearney, M ;
Walsh, K ;
Isner, JM .
CIRCULATION, 1998, 97 (12) :1114-1123
[6]   Small-diameter vascular graft prostheses: Current status [J].
Bos, GW ;
Poot, AA ;
Beugeling, T ;
van Aken, WG ;
Feijen, J .
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1998, 106 (02) :100-115
[7]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[8]   IMPLANTABLE BIOHYBRID ARTIFICIAL ORGANS [J].
COLTON, CK .
CELL TRANSPLANTATION, 1995, 4 (04) :415-436
[9]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[10]   Long-term studies of cold-stored rabbit femoral artery and vein autografts [J].
Crowe, DM ;
Hurley, JV ;
Mitchell, GM ;
Niazi, Z ;
Morrison, WA .
BRITISH JOURNAL OF PLASTIC SURGERY, 1998, 51 (04) :291-299